insights_auto
Why is ALCOX down 3.51%?
Dive Deeperchevron_right
ALCOX:EPA
NicOx SA
€0.30
arrow_downward
-3.51%(-0.011) 1D
Oct 8, 1:20:57 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALCOX...
Open
€0.31
High
€0.31
Low
€0.30
Mkt. cap
30.00M
Avg. vol.
165.85K
Volume
109.60K
52-wk high
€0.57
52-wk low
€0.28
EPS
-€0.03
Shares outstanding
97.55M
No. of employees
10
Open
€0.31
High
€0.31
Low
€0.30
Mkt. cap
30.00M
Avg. vol.
165.85K
Volume
109.60K
52-wk high
€0.57
52-wk low
€0.28
EPS
-€0.03
Shares outstanding
97.55M
No. of employees
10
News stories
From web sources and news partners
Quartz
·
8 minutes ago
Dow futures fall 500 points as oil prices surge above $105
TradingView
·
36 minutes ago
US Futures Slump on Thursday
24/7 Wall St.
·
18 minutes ago
3 Stocks That Have More Than Doubled the S&P 500’s Return This Year
AOL.com
·
33 minutes ago
Dell Turned $1,000 Into $11,641 in Five Years as AI Servers Crushed the S&P 500
Profile
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
About NicOx SA
CEO-
Employees10
Founded1996
HeadquartersValbonne, Provence-Alpes-Côte d'Azur, France
SectorBiotechnology
Websitenicox.com